Lv4
460 积分 2021-06-08 加入
Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer
17小时前
待确认
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
3个月前
已完结
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
3个月前
已完结
Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices
3个月前
已完结
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis
4个月前
已完结
Intraperitoneal Chemotherapy
4个月前
已完结
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer
4个月前
已完结
Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients
4个月前
已完结
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
4个月前
已完结
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study
4个月前
已完结
皖公网安备34019202002308
